Keywords: Alzheimer's Disease, Alzheimer's Disease
Motivation: AD-RAI is a novel MRI-based machine-learning derived biomarker and the value of longitudinal AD-RAI remains unclear.
Goal(s): We aimed to assess longitudinal changes of the MRI biomarkers (i.e., AD-RAI, HV, HF, BPV, BPF) in correlation with change in time and conversion status with and without A+T+.
Approach: We selected 168 CU and MCI in ADNI with four-year follow-up with serial MRI scans and corresponding CSF and used linear mixed-effects models to estimate and compare.
Results: AD-RAI of subjects with A+T+ increased significantly faster than non-A+T+ over time and AD-RAI has the potential to track CSF Aβ1–42 as an effective longitudinal surrogate biomarker.
Impact: If the serial AD-RAI change over time is associated with conversion status and AD pathologies. It may be used as a surrogate marker for monitoring disease progression or treatment response in AD.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords